跳至主要内容
临床试验/NCT03034122
NCT03034122已完成不适用

Is Caffeine an Environmental Modifier in Huntington's Disease?

University Hospital, Lille10 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2017年10月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
77
试验地点
10
主要终点
Change in striatal volume

研究概览

简要总结

The aim of the study is to establish if caffeine consumption is associated with the evolution of the disease in premanifest HD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •HD mutation carriers (>36 CAG)
  • •premanifest (total motor UHDRS < 5)
  • •estimated time to diagnosis between 3 and 10 years
  • •adults older than 21 years (in order to exclude juvenile patients who begin the disease before 21 years)
  • •informed consent signed
  • •with a social protection

排除标准

  • •MRI contraindication
  • •pregnant and lactating women
  • •People under guardianship, trusteeship, deprive of freedom

结局指标

主要结局

Change in striatal volume

时间窗: at 2 years

次要结局

  • Unified Huntington's Disease Rating Scale (UHDRS)(at 1 years, at 2 years)
  • PBA (problem behaviors assessment)(at 1 years, at 2 years)
  • Stroop test(at 1 years, at 2 years)
  • score at Epworth sleepiness scale(at 1 years, at 2 years)
  • SDMT -symbol digit modality test(at 1 years, at 2 years)
  • MRI(at 1 years, at 2 years)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验